Insider · CIK 0001703090
James Paul Lang
Files at HALO (HALOZYME THERAPEUTICS, INC.), OPRX (OptimizeRx Corp), BIVI (BIOVIE INC.). First filing -, latest -.
James Paul Lang files SEC Form 4 as director at HALO (HALOZYME THERAPEUTICS, INC.), and also at OPRX (OptimizeRx Corp), BIVI (BIOVIE INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James Paul Lang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Jan 9, 2026 |
| Jan 5, 2026 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +330,500 | $0.00 | $0 | 330,500 | Jan 9, 2026 |
| Jan 2, 2026 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Restricted Stock Units | +889 | $0.00 | $0 | 889 | Jan 6, 2026 |
| Jan 2, 2026 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Option to Purchase Common Stockderivative | +1,342 | $0.00 | $0 | 1,342 | Jan 6, 2026 |
| Jun 11, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +9,868 | $0.00 | $0 | 399,320 | Jun 12, 2025 |
| Nov 20, 2024 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +61,600 | $0.00 | $0 | 61,600 | Jan 7, 2025 |
| Dec 20, 2024 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +22,690 | $0.00 | $0 | 22,690 | Jan 7, 2025 |
Questions about James Paul Lang
Answered from the filings on this page, as of the latest one.
Is James Paul Lang buying or selling?
James Paul Lang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James Paul Lang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Paul Lang has 0.
Where does James Paul Lang file Form 4?
James Paul Lang has filed Form 4 at HALO (HALOZYME THERAPEUTICS, INC.); OPRX (OptimizeRx Corp); BIVI (BIOVIE INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.